Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!

Research output: Contribution to journalLetterResearchpeer-review

DOI

  1. Management of anaphylaxis due to COVID-19 vaccines in the elderly

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold- An ARIA-EAACI-GA2 LENconsensus

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Beta2 -adrenergic agonists can enhance intense performance and muscle strength in healthy individuals

    Research output: Contribution to journalLetterResearchpeer-review

  4. Diagnosing, managing and preventing anaphylaxis: Systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  5. ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020)

    Research output: Contribution to journalLetterResearchpeer-review

  1. Optimizing investigation of suspected allergy to polyethylene glycols

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Facial contact dermatitis caused by cosmetic-relevant allergens

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Hypersensitivity to vitamins with a focus on immediate-type reactions: Food or drug allergy?

    Research output: Contribution to journalReviewResearchpeer-review

  4. The passively sensitized mast cell activation test is a reliable diagnostic for chlorhexidine allergy

    Research output: Contribution to journalLetterResearchpeer-review

View graph of relations
Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume76
Issue number9
Pages (from-to)2916-2920
Number of pages5
ISSN0105-4538
DOIs
Publication statusPublished - Sep 2021

    Research areas

  • anaphylaxis, SARS-CoV, vaccines, COVID-19, SARS-CoV-2, Anaphylaxis, COVID-19 Vaccines, Humans, RNA, Messenger

ID: 67623838